By Gerald Flattmann, Vanessa Yen and Evan Diamond ( January 17, 2019, 4:56 PM EST) -- On Jan. 11, 2019, the U.S. Court of Appeals for the Federal Circuit issued a precedential opinion in Amerigen Pharmaceuticals Ltd. v. UCB Pharma GmbH[1] affirming the decision of the Patent Trial and Appeal Board in an inter partes review proceeding finding that a pharmaceutical patent directed to "prodrug" compounds was not unpatentable as obvious. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.